Cypress Capital Group Thermo Fisher Scientific Inc. Transaction History

Cypress Capital Group

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$498.29 - $574.41 $71,255 - $82,140	-143 Reduced 16.49%	724 $366,000
Q2 2023 Jul 26, 2023	BUY	$508.46 - $591.13 $176,435 - $205,122	347 Added 66.73%	867 $452,000
Q1 2023 May 04, 2023	BUY	$535.0 - $604.82 $56,175 - $63,506	105 Added 25.3%	520 $299,000
Q4 2022 Feb 14, 2023	BUY	$484.71 - $571.37 $201,154 - $237,118	415 New	415 $228,000
Q2 2022 Jul 26, 2022	SELL	$500.9 - $612.21 $346,121 - $423,037	-691 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$524.0 - $644.92 $165,060 - $203,149	315 Added 83.78%	691 $408,000
Q4 2021 Feb 15, 2022	SELL	$569.0 - $667.24 $80,798 - $94,748	-142 Reduced 27.41%	376 $251,000
Q3 2021 Oct 12, 2021	BUY	$509.53 - $609.78 $26,495 - $31,708	52 Added 11.16%	518 $296,000
Q2 2021 Jul 13, 2021	SELL	$441.0 - $508.24 $93,933 - $108,255	-213 Reduced 31.37%	466 $235,000
Q1 2021 Apr 14, 2021	SELL	$439.85 - $518.83 $48,383 - $57,071	-110 Reduced 13.94%	679 $310,000
Q4 2020 Jan 12, 2021	BUY	$435.06 - $527.66 $98,758 - $119,778	227 Added 40.39%	789 $368,000
Q3 2020 Oct 08, 2020	BUY	$359.77 - $441.52 $202,190 - $248,134	562 New	562 $248,000
Q1 2020 Apr 08, 2020	SELL	$255.3 - $340.05 $158,286 - $210,831	-620 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$271.93 - $328.04 $168,596 - $203,384	620 New	620 $201,000
Q3 2019 Oct 10, 2019	SELL	$268.46 - $305.43 $248,593 - $282,828	-926 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$257.51 - $295.55 $24,720 - $28,372	96 Added 11.57%	926 $272,000
Q1 2019 May 14, 2019	BUY	$212.17 - $273.72 $176,101 - $227,187	830 New	830 $227,000

2,832

334M

2.37M

2.75M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $204B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Group with notifications on news.